Annals of Pharmacotherapy

ISSN 1060-0280 · SAGE Publishing · United States · active 1975–2026

Metrics

Scimago quartile
Q2
Cites per paper (2y)
1.6
SJR
0.815
h-index
152

“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.

Indexing & access

ScopusWeb of SciencePubMed

Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.

Scope

pharmaceuticalpracticespatientoutcomesgeriatricsgerontologypediatricsperinatologychildhealthantibioticspharmacokinetics

Frequently asked

Is Annals of Pharmacotherapy a predatory journal?

Our screening does not flag Annals of Pharmacotherapy. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.

Is Annals of Pharmacotherapy indexed in Scopus or Web of Science?

Per our venue index, Annals of Pharmacotherapy appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.

What is Annals of Pharmacotherapy's impact?

Papers in Annals of Pharmacotherapy are cited about 1.6 times each within two years of publication, and Scimago places it in Q2, with an h-index of 152. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.

Is Annals of Pharmacotherapy open access?

We hold no reliable open-access classification for Annals of Pharmacotherapy. Check the journal's own site for its access model and any article processing charge.

Similar venues

Command palette

Jump anywhere, run any action.